Published in TB and Outbreaks Week, August 23rd, 2005
According to recent research from New Zealand and England, "Priming neonatal calves at birth with a Mycobacterium bovis bacillus Calmette-Guerin (BCG) vaccine and boosting with a DNA vaccine consisting of plasmids encoding mycobacterial antigens Hsp65, Hsp70, and Apa or the reverse prime-boost sequence induced similar levels of protection against experimental challenge with Mycobacterium bovis."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week